Obstetrics & gynaecology

Novel misoprostol insert reduces labor time, need for oxytocin

(HealthDay)—Use of a 200-microgram misoprostol vaginal insert significantly reduces the time to vaginal delivery and the need for oxytocin, in women with an unfavorable cervix, compared to those using a dinoprostone vaginal ...

Medical research

Discovery may lead to safer drugs to save more women in childbirth

Postpartum hemorrhaging is the world's leading cause of death for women during and after childbirth, and the third-leading cause in the United States alone. Many doctors in developing countries have turned to the drug misoprostol ...

Obstetrics & gynaecology

Misoprostol doesn't cut risk of postpartum hemorrhage

(HealthDay)—For women in the third stage of labor, misoprostol administered with routine oxytocin does not reduce the rate of postpartum hemorrhage, according to a study published online Sept. 5 in Obstetrics & Gynecology.

page 1 from 2